Cargando…
Cumulative exposure to tacrolimus and incidence of cancer after liver transplantation
Cancer is the leading cause of death after liver transplantation (LT). This multicenter case–control nested study aimed to evaluate the effect of maintenance immunosuppression on post‐LT malignancy. The eligible cohort included 2495 LT patients who received tacrolimus‐based immunosuppression. After...
Autores principales: | Rodríguez‐Perálvarez, Manuel, Colmenero, Jordi, González, Antonio, Gastaca, Mikel, Curell, Anna, Caballero‐Marcos, Aránzazu, Sánchez‐Martínez, Ana, Di Maira, Tommaso, Herrero, José Ignacio, Almohalla, Carolina, Lorente, Sara, Cuadrado‐Lavín, Antonio, Pascual, Sonia, López‐Garrido, María Ángeles, González‐Grande, Rocío, Gómez‐Orellana, Antonio, Alejandre, Rafael, Zamora‐Olaya, Javier, Bernal‐Bellido, Carmen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9315045/ https://www.ncbi.nlm.nih.gov/pubmed/35286761 http://dx.doi.org/10.1111/ajt.17021 |
Ejemplares similares
-
Donation after circulatory death liver transplantation: consensus statements from the Spanish Liver Transplantation Society
por: Hessheimer, Amelia J., et al.
Publicado: (2020) -
Early tacrolimus exposure does not impact long-term outcomes after liver transplantation
por: Gastaca, Mikel, et al.
Publicado: (2021) -
Circulating Tumor Cells in Hepatocellular Carcinoma: A Comprehensive Review and Critical Appraisal
por: Espejo-Cruz, María Lola, et al.
Publicado: (2021) -
Reply to: “Age and comorbidity are central to the risk of death from COVID-19 in liver transplant recipients”
por: Rodríguez-Perálvarez, Manuel, et al.
Publicado: (2021) -
Enumeration and Characterization of Circulating Tumor Cells in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization
por: Espejo-Cruz, María L., et al.
Publicado: (2023)